Compounds > diminazene

diminazene and Autoimmune Diabetes

diminazene has been researched along with Autoimmune Diabetes in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Gaikwad, AB; Kale, A; Sankrityayan, H1
Gaikwad, AB; Malek, V; Sharma, N1

Other Studies

2 other study(ies) available for diminazene and Autoimmune Diabetes

ArticleYear
Inhibition of endoplasmic reticulum stress combined with activation of angiotensin-converting enzyme 2: novel approach for the prevention of endothelial dysfunction in type 1 diabetic rats.
    Canadian journal of physiology and pharmacology, 2022, Volume: 100, Issue:3

    Topics: Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diminazene; Drug Therapy, Combination; Endoplasmic Reticulum Stress; Endothelium, Vascular; Male; Oxidative Stress; Rats, Wistar; Streptozocin; Taurochenodeoxycholic Acid

2022
Simultaneous inhibition of neprilysin and activation of ACE2 prevented diabetic cardiomyopathy.
    Pharmacological reports : PR, 2019, Volume: 71, Issue:5

    Topics: Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Diminazene; Drug Therapy, Combination; Enzyme Activation; Male; Neprilysin; Peptidyl-Dipeptidase A; Rats, Wistar; Streptozocin; Thiorphan

2019